Acceptable cost for the patient and society

Slides:

Advertisements

Similar presentations

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States David B. Seifer, M.D., Valerie.

Advertisements

International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003 Karl G. Nygren,

Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient.

International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2005 Fernando Zegers-Hochschild,

How effective is in vitro fertilization, and how can it be improved?

Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication Thamara Viloria,

Age at menarche: a predictor of diminished ovarian function?

Fertility and Sterility Volume 97, Issue 3, Pages (March 2012)

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

Infertility evaluation and treatment among women in the United States

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States Jennifer.

A prospective, randomized, double-blinded study of assisted hatching in women younger than 38 years undergoing in vitro fertilization Andrea R. Hagemann,

Michael M. Alper, M.D. Fertility and Sterility

Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials Ana Cobo, Ph.D., César Diaz, M.D.

Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J

Marcos Meseguer, Ph. D. , Rebeca Santiso, Ph. D. , Nicolás Garrido, Ph

Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases Mahesh.

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study Leonidas Mamas, M.D., Ph.D.

Temporal trends in clomiphene citrate use: a population-based study

Medical treatment of ectopic pregnancy: a committee opinion

In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors Ahmad O. Hammoud, M.D.,

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

The impact of consumer affordability on access to assisted reproductive technologies and embryo transfer practices: an international analysis Georgina.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Insurance mandates and trends in infertility treatments

Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient.

Assisted reproductive technology use, embryo transfer practices, and birth outcomes after infertility insurance mandates: New Jersey and Connecticut

Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes Jin-Ho Lim, M.D., Seong-Ho Yang,

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Martin D. Keltz, M. D. , Josh C. Skorupski, M. D. , Katrina Bradley, M

Oocyte cryopreservation

Assisted reproductive technology in the United States: 2000 results generated from the American Society for Reproductive Medicine/Society for Assisted.

Assisted reproductive technology in the United States: 1999 results generated from the American Society for reproductive medicine/society for assisted.

Comprehensive evaluation of contemporary assisted reproduction technology laboratory operations to determine staffing levels that promote patient safety.

Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention Dmitry M. Kissin, M.D.,

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Calculating cumulative live-birth rates from linked cycles of assisted reproductive technology (ART): data from the Massachusetts SART CORS Judy E. Stern,

Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle Nancy J. Kenney,

Sean Ackerman, M. D. , Julia Wenegrat, M. A. , David Rettew, M. D

Rodrigo Borsari, M. D. , Nilo Bozzini, Ph. D

Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,

Clomiphene citrate at 50: the dawning of assisted reproduction

Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States Judy E. Stern, Ph.D., Marcelle I.

Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles Karin.

Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low.

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Thomas M. D’Hooghe, M. D. , Ph. D. , Bénédicte Denys, M. D

Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,

Birth outcomes after spontaneous or assisted conception among infertile Australian women aged 28 to 36 years: a prospective, population-based study Danielle.

Jennifer F. Kawwass, M. D. , Sara Crawford, Ph. D. , Donna R

One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above Sigal Klipstein, M.D., Meredith.

Clazien A. M. Bouwmans, M. Sc. , Bea M. E. Lintsen, M. D. , Marinus J

José Bellver, M. D. , Yanira Ayllón, M. D. , Marcos Ferrando, M. D

In vitro fertilization and breast cancer: is there cause for concern?

Transient abdominal ovariopexy for adhesion prevention in patients who underwent surgery for severe pelvic endometriosis Jonathan Ouahba, M.D., Patrick.

Regulation of assisted reproductive technologies in the United States

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Redefining the relationship between sperm deoxyribonucleic acid fragmentation as measured by the sperm chromatin structure assay and outcomes of assisted.

Fertility and Sterility: an evaluation

Temporal and geospatial trends in male factor infertility with assisted reproductive technology in the United States from 1999–2010 Anobel Y. Odisho,

International Committee for Monitoring Assisted Reproductive Technologies: World Report on Assisted Reproductive Technologies, 2007 Osamu Ishihara, M.D.,

Current evaluation of amenorrhea

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph

Soluble HLA-G in the peritoneal fluid of women with endometriosis

Society for Assisted Reproductive Technology and assisted reproductive technology in the United States: a 2016 update James P. Toner, M.D., Ph.D., Charles.

The cumulative probability of liveborn multiples after in vitro fertilization: a cohort study of more than 10,000 women Beth A. Malizia, M.D., Laura.

Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society.

Presentation transcript:

Acceptable cost for the patient and society Georgina M. Chambers, Ph.D., G. David Adamson, M.D., Marinus J.C. Eijkemans, Ph.D. Fertility and Sterility Volume 100, Issue 2, Pages 319-327 (August 2013) DOI: 10.1016/j.fertnstert.2013.06.017 Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Direct cost of a fresh IVF cycle before government of third-party subsidization 2006/2007. Purchasing power parity and average 2006 interbank exchange rates were used to convert all currencies to 2006 USA. Costs include pharmaceuticals. Fertility and Sterility 2013 100, 319-327DOI: (10.1016/j.fertnstert.2013.06.017) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Affordability of assisted reproductive technology (ART) treatment, 2006/2007. ART affordability is expressed as the net cost of a fresh IVF cycle as a percentage of annual disposable income of a single person earning 100% of average wages with no dependent children. Disposable income is calculated according to Organisation for Economic Co-operation and Development (OECD) methods (16). United States (Mandated) denotes data from a sample of three US states with comprehensive insurance mandates for ART (Connecticut, Massachusetts, New Jersey). United States (non-mandated) denotes data from a sample of three US states with no fertility treatment mandates (Michigan, Oregon, Washington). Fertility and Sterility 2013 100, 319-327DOI: (10.1016/j.fertnstert.2013.06.017) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Assisted reproductive technology (ART) affordability and utilization, 2006/2007. ART Affordability is expressed as the net cost of a fresh IVF cycle as a percentage of annual disposable income of a single person earning 100% of average wages with no dependent children. Disposable income is calculated according to Organisation for Economic Co-operation and Development (OECD) methods (16). Utilization is expressed as the number of fresh autologous cycles per one million women of reproductive age (15–49 years). Fertility and Sterility 2013 100, 319-327DOI: (10.1016/j.fertnstert.2013.06.017) Copyright © 2013 American Society for Reproductive Medicine Terms and Conditions